Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 58, Issue 3, 2017, Pages 909-918

  Sala, Isabel ^a,c   Illán Gala, Ignacio ^a,c   Alcolea, Daniel ^a,c   Sánchez Saudinós, Ma Belén ^a,c   Salgado, Sergio Andrés ^a   Morenas Rodríguez, Estrella ^a,c   Subirana, Andrea ^a,c   Videla, Laura ^a,b,c   Clarimón, Jordi ^a,c   Carmona Iragui, María ^a,b,c   Ribosa Nogué, Roser ^a,c   Blesa, Rafael ^a,c   Fortea, Juan ^a,b,c   Lleó, Alberto ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Barcelona Down Medical Center   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Alzheimer's disease; biomarkers; cerebrospinal fluid; episodic memory; mild cognitive impairment; mild neurocognitive disorder; neuropsychological test

Indexed keywords

TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E; BIOLOGICAL MARKER; MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; ASSESSMENT OF HUMANS; CEREBROSPINAL FLUID; CLINICAL EVALUATION; CLINICAL PRACTICE; CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FOLLOW UP; FREE AND CUED SELECTIVE REMINDING TEST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECALL; VERBAL MEMORY; WORD LIST RECALL; COGNITIVE DEFECT; COMPLICATION; DISEASE EXACERBATION; EVALUATION STUDY; GENETICS; MEMORY; PROPORTIONAL HAZARDS MODEL; SPEECH PERCEPTION; STATISTICAL MODEL;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BIOMARKERS; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SPEECH PERCEPTION; TAU PROTEINS;

EID: 85020455602     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-170073     Document Type: Article

References (44)

1. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194.
2. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, Dekosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert M-O, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria. Lancet Neurol 13, 614-629.
3. Albert MS, Dekosky ST, Dickson DW, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
4. Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological Assessment, Oxford University Press.
5. Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frolich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz H-J, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J (2012) Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology 78, 379-386.
6. Quenon L, Dricot L, Woodard JL, Hanseeuw B, Gilis N, Lhommel R, Ivanoiu A (2016) Prediction of free and cued selective reminding test performance using volumetric and amyloid-based biomarkers of Alzheimer's disease. J Int Neuropsychol Soc 22, 991-1004.
7. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
8. Wolk DA, Dunfee KL, Dickerson BC, Aizenstein HJ, Dekosky ST (2011) A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease. Hippocampus 21, 461-466.
9. Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A (2008) Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty years. Alzheimers Dement 4, 96-109.
10. Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B (2007) Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology 69, 1859-1867.
11. Derby CA, Burns LC, Wang C, Katz MJ, Zimmerman ME, L'italien G, Guo Z, Berman RM, Lipton RB (2013) Screening for predementia AD: Time-dependent operating characteristics of episodic memory tests. Neurology 80, 1307-1314.
12. Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly TN, Touchon J, Dubois B, Berr C (2014) Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry 85, 363-370.
13. Lemos R, Afonso A, Martins C, Waters JH, Blanco FS, Simões MR, Santana I (2015) Selective reminding and free and cued selective reminding in mild cognitive impairment and Alzheimer disease. Appl Neuropsychol Adult 23, 85-93.
14. Dong A, Toledo JB, Honnorat N, Doshi J, Varol E, Sotiras A, Wolk D, Trojanowski JQ, Davatzikos C, Alzheimer's Disease Neuroimaging Initiative (2017) Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: Links to cognition, progression and biomarkers. Brain 140, 735-747.
15. Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H (2015) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement 11, 58-69.
16. Serrano-Pozo A, Qian J, Monsell SE, Blacker D, Gomez-Isla T, Betensky RA, Growdon JH, Johnson KA, Frosch MP, Sperling RA, Hyman BT (2014) Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol 75, 597-601.
17. Gainotti G, Quaranta D, Vita MG, Marra C (2014) Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 38, 481-495.
18. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
19. Peña-Casanova J, Blesa R, Aguilar M, Gramunt-Fombuena N, Gómez-Ansón B, Oliva R, Molinuevo JL, Robles A, Barquero MS, Antúnez C, Martínez-Parra C, Frank-García A, Fernández M, Alfonso V, Sol JM, Neuronorma Study Team (2009) Spanish Multicenter Normative Studies (NEURONORMA Project): Methods and sample characteristics. Arch Clin Neuropsychol 24, 307-319.
20. Van Den Eeden SK, Nelson LM, Tanner CM, McGuire V (2004) Regional North American Annual Meeting of the World Federation of Neurology - Research Group on Neuroepidemiology. Neuroepidemiology 23, 151-158.
21. Alcolea D, Martínez-Lage P, Sánchez-Juan P, Olazarán J, Antúnez C, Izagirre A, Ecay-Torres M, Estanga A, CleriguéM, Guisasola MC, Sánchez Ruiz D, Marín Muñoz J, Calero M, Blesa R, Clarimon J, Carmona-Iragui M, Morenas-Rodríguez E, Rodriguez-Rodriguez E, Vázquez-Higuera JL, Fortea J, Lleo A (2015) Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology 85, 626-633.
22. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
23. Vos SJB, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BNM, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S, Alzheimer's Disease Neuroimaging Initiative, Freund-Levi Y, Wallin A K, Hampel H, van der Flier W, Scheltens P, Visser PJ (2015) Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain 138, 1327-1338.
24. Alcolea D, Carmona-Iragui M, Suárez-Calvet M, Sánchez-Saudinós MB, Sala I, Antón-Aguirre S, Blesa R, Clarimon J, Fortea J, Lleo A (2014) Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 42, 157-167.
25. Mattsson N, Andreasson U, Persson S, Carrillo MC, Collins S, Chalbot S, Cutler N, Dufour-Rainfray D, Fagan AM, Heegaard NHH, Robin Hsiung G-Y, Hyman B, Iqbal K, Kaeser SA, Käser SA, Lachno DR, Lleo A, Lewczuk P, Molinuevo JL, Parchi P, Regeniter A, Rissman RA, Rissman R, Rosenmann H, Sancesario G, Schröder J, Shaw LM, Teunissen CE, Trojanowski JQ, Vanderstichele H, Vandijck M, Verbeek MM, Zetterberg H, Blennow K, Alzheimer's Association QC Program Work Group (2013) CSF biomarker variability in the Alzheimer's Association quality control program. Alzheimers Dement 9, 251-261.
26. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM-Y, Trojanowski JQ, Alzheimer's Disease Neuroimaging Initiative (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413.
27. Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka SK, Hampel H, de Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM (2014) The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean? Alzheimers Dement 10, 713-723.e2.
28. Calero O, Hortigüela R, Bullido MJ, Calero M (2009) Apolipoprotein E genotyping method by real time PCR, a fast and cost-effective alternative to the TaqMan and FRET assays. J Neurosci Methods 183, 238-240.
29. Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB, Alzheimer's Disease Neuroimaging Initiative (2015) Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology 84, 508-515.
30. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gómez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, LeeV MY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Consortium onDLB (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65, 1863-1872.
31. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini M-L, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Neurology 134, 2456-2477.
32. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
33. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
34. Brugnolo A, Morbelli S, Arnaldi D, De Carli F, Accardo J, Bossert I, Dessi B, Famà F, Ferrara M, Girtler N, Picco A, Rodriguez G, Sambuceti G, Nobili F (2014) Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints. J Alzheimers Dis 39, 103-113.
35. Sarazin M, Chauviré V, Gerardin E, Colliot O, Kinkingnéhun S, de Souza LC, Hugonot-Diener L, Garnero L, Lehericy S, Chupin M, Dubois B (2010) The amnestic syndrome of hippocampal type in Alzheimer's disease: An MRI study. J Alzheimers Dis 22, 285-294.
36. Philippi N, Noblet V, Duron E, Cretin B, Boully C, Wisniewski I, Seux ML, Martin-Hunyadi C, Chaussade E, Demuynck C, Kremer S, Lehéricy S, Gounot D, Armspach JP, Hanon O, Blanc F (2016) Exploring anterograde memory: Avolumetric MRI study in patients with mild cognitive impairment. Alzheimers Res Ther 8, 1-14.
37. Xie J, Gabelle A, Dorey A, Garnier-Crussard A, Perret-Liaudet A, Delphin-Combe F, Bathsavanis A, Dauphinot V, Lehmann S, Mercier B, Desestret V, Roullet-Solignac I, Vighetto A, Krolak-Salmon P (2014) Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature. J Alzheimers Dis 41, 1109-1116.
38. Edmonds EC, Delano-Wood L, Clark LR, Jak AJ, Nation DA, McDonald CR, Libon DJ, Au R, Galasko D, Salmon DP, Bondi MW, Alzheimer's Disease Neuroimaging Initiative (2015) Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement 11, 415-424.
39. Edmonds EC, Eppig J, Bondi MW, Leyden KM, Goodwin B, Delano-Wood L, McDonald CR, Alzheimer's Disease Neuroimaging Initiative (2016) Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria. Neurology 87, 2108-2116.
40. Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): A common pathology associated with human aging. Acta Neuropathol 128, 755-766.
41. Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJB (2016) Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nat Rev Neurol 12, 117-124.
42. Bertoux M, de Souza LC, Corlier F, Lamari F, Bottlaender M, Dubois B, Sarazin M (2014) Two distinct amnesic profiles in behavioral variant frontotemporal dementia. Biol Psychiatry 75, 582-588.
43. Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR (2013) Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol 74, 199-208.
44. Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX, Lee VMY, Shaw LM, Trojanowski JQ (2012) CSF biomarkers cutoffs: The importance of coincident neuropathological diseases. Acta Neuropathol 124, 23-35.